- Udyam number
- UDYAM-GJ-17-0007235

Avyansh Formulations Private Limited
About Avyansh Formulations Private Limited
Data last updated:
Avyansh Formulations Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 October 2022.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2022PTC136292.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Chandrikaben Vishnubhai Patel and Jay Chaturbhai Butani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop 1 Lifeline Complex Shiyapura Raopura, Vadodara, Gujarat, India – 390001.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.48 Cr, a growth of 123% compared to the previous year. For the same year it recorded a net profit of ₹56.31 Lakh (net margin 1.5%) and EBITDA of ₹1.19 Cr (EBITDA margin 3.2%).
The company has about 10 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹8.15 Cr on record.
Avyansh Formulations Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-17-0007235).
Company details
Recognitions & Rankings of Avyansh Formulations
Contact details
Avyansh Formulations Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressShop 1 Lifeline Complex Shiyapura Raopura, Vadodara, Gujarat, India – 390001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Avyansh Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avyansh Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Avyansh Formulations Private Limited, buy the company report.
Financials of Avyansh Formulations Private Limited
FY 2025 filings availableAvyansh Formulations Private Limited reported revenue of ₹37.48 Cr (up 123% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 123% in the latest year. EBITDA fell 13% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.19 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹56.31 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.2% | ||
| Net Profit Margin | 1.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Avyansh Formulations Private Limited, buy the company report.
Board of directors of Avyansh Formulations Private Limited
Avyansh Formulations has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrikaben Vishnubhai Patel Also directs: Acnova Pharmaceuticals Private Limited | Director | 19 Oct 2022 | 4 Years 0 Months | Current |
| Jay Chaturbhai Butani | Director | 19 Oct 2022 | 4 Years 0 Months | Current |
| Mitenkumar Ashokbhai Shah | Director | 19 Oct 2022 | 4 Years 0 Months | Current |
| Nirajkumar Ashokkumar Shah | Director | 19 Oct 2022 | 4 Years 0 Months | Current |
| Yatinkumar Vishnubhai Patel | Director | 19 Oct 2022 | 4 Years 0 Months | Current |
Peer comparison
Avyansh Formulations Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VVR Organics Private Limited | ₹38.01 Cr (FY 2024) | 9.0% | Hyderabad, Telangana, India | |||
| Purogene Labs Private Limited | ₹37.79 Cr (FY 2025) | 36.0% | Hyderabad, Telangana, India | |||
| Ivpex Parenteral Private Limited | ₹37.61 Cr (FY 2025) | 5.0% | Baddi, Himachal Pradesh, India | |||
| Titanium Technologies (India) Private Limited | ₹37.49 Cr (FY 2024) | 60.0% | New Delhi, Delhi, India | |||
| Avyansh Formulations Private Limitedthis company | ₹37.48 Cr (FY 2025) | ₹56.31 Lakh | 1.5% | 123.0% | Vadodara, Gujarat, India | |
| Garima Healthcare Private Limited | ₹37.46 Cr (FY 2025) | 15.0% | Indore, Madhya Pradesh, India | |||
| Raut Serums India Private Limited | ₹37.44 Cr (FY 2025) | 35.0% | Pune, Maharashtra, India | |||
| Savvy Care & Cosmetics Private Limited | ₹37.12 Cr (FY 2024) | 25.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Avyansh Formulations Private Limited, buy the company report.
Auditor
Avyansh Formulations Private Limited is audited by Manish Dubal & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Manish Dubal & Associates | FY 2023 | 123305 |
Shareholding
The shareholding of Avyansh Formulations Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Avyansh Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jan 2023 | 100667751 | Others | ₹4 Cr | Open | |
| 24 Jan 2023 | 100668949 | Others | ₹15 Lakh | Open | |
| 04 Jan 2023 | 100667974 | Others | ₹4 Cr | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Avyansh Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avyansh Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Avyansh Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Avyansh Formulations Private Limited has 5 board changes on record since 2022: 5 appointments. The latest: Chandrikaben Vishnubhai Patel was appointed as Director on 19 Oct 2022.
Frequently asked questions
Avyansh Formulations is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 October 2022 (4+ years old) and is registered under CIN U24290GJ2022PTC136292.
Avyansh Formulations has 5 current directors:
- Chandrikaben Vishnubhai Patel - Director
- Jay Chaturbhai Butani - Director
- Mitenkumar Ashokbhai Shah - Director
- Nirajkumar Ashokkumar Shah - Director
- Yatinkumar Vishnubhai Patel - Director
The latest financial statements of Avyansh Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Avyansh Formulations is U24290GJ2022PTC136292. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avyansh Formulations was incorporated on 19 October 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Avyansh Formulations by revenue are VVR Organics Private Limited, Purogene Labs Private Limited, Ivpex Parenteral Private Limited, Titanium Technologies (India) Private Limited, Garima Healthcare Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chandrikaben Vishnubhai Patel was appointed as Director on 19 Oct 2022. Jay Chaturbhai Butani was appointed as Director on 19 Oct 2022. Mitenkumar Ashokbhai Shah was appointed as Director on 19 Oct 2022. Avyansh Formulations has 5 board changes on record in total.
Yes, Avyansh Formulations is registered as an MSME under Udyam registration (number: UDYAM-GJ-17-0007235).
The registered office of Avyansh Formulations is at Shop 1 Lifeline Complex Shiyapura Raopura, Vadodara, Gujarat, India – 390001.
Avyansh Formulations operates in the pharma industry, in the drug formulation and development segment.
Avyansh Formulations has open charges of ₹8.15 Cr and no satisfied charges on record as per latest MCA filings.

